COPD trials in Estonia

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  Where

  Tallinn, Tartu

  Age

  40 years to 80 years

  People

  942 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07190209 · EU 2024-518016-39-00
• Phase 3Enrolling by invitation
  Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency

  Where

  Tallinn

  Age

  20 years to 72 years

  People

  290 worldwide

  Run by

  Grifols Therapeutics LLC

  See details and how to joinNCT02796937